Medexus Pharmaceuticals
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Place Du Commerce Suite 225, Verdun, Q...Phone Number
(514) 762-2626Website
www.medexus.comRevenue
$115.7 MillionStock Symbol
MEDXFIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Medexus Pharmaceuticals
Medexus Pharmaceuticals is a leading innovative and rare disease, pharmaceutical company with a strong North American commercial platform. Medexus Pharmaceuticals is headquartered in Ontario, Canada.Explore more
Medexus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medexus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Medexus Pharmaceuticals has new funding data
Product Launch: Get notified when Medexus Pharmaceuticals launches new products
Earning: See what the market has to say on Medexus Pharmaceuticals recently announced quarterly report
Click to see if Medexus Pharmaceuticals had a recent Job posting/layoffs
Check out if Medexus Pharmaceuticals is spiking on competitors!
Check if Medexus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Medexus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Medexus Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Medexus Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Medexus Pharmaceuticals
Compare insights from companies similar to Medexus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medexus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medexus Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medexus Pharmaceuticals.
Medexus Pharmaceuticals financials insights
Gather financial insights about Medexus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$25M
Medexus Pharmaceuticals Tech Stack
A closer look at the technologies used by Medexus Pharmaceuticals
See more technologies
Most Recent Scoops
Earnings
Medexus Pharmaceuticals has indicated that a 15% EU-US negotiated tariff is expected to apply to Rasuvo, while the same 15% tariff could apply to GRAFAPEX with a potential orphan drug carve-out still being monitored, noting that the overall impact on margins is not expected to be material and no tariff-specific price changes are anticipated.
Pricing
Earnings
Medexus Pharmaceuticals has reported that wholesaler inventory levels for GRAFAPEX were approximately one month's worth of inventory as of June 30, 2026, consistent with levels as of March 31, 2026, down from two-plus months at initial launch, with this stability explaining the consistency between demand sales and ex-factory sales.
Logistics / Supply Chain, Inventory Management
Project
Medexus Pharmaceuticals has requested a meeting with Health Canada to discuss the regulatory path forward for its Canadian product candidate, with the meeting expected to occur in the fall and optimism expressed about a potential expedited pathway given the product's Canadian development origin and significant unmet medical need.
Governmental Affairs & Regulation, Regulations
Earnings
Medexus Pharmaceuticals has expressed continued confidence in its full-year fiscal 2027 GRAFAPEX net revenue guidance of $30 to $32 million, supported by leading indicators including formulary listings, commercial payer support, and first hospital use, with July 2027 reported as the second best revenue month ever for GRAFAPEX despite historically being a soft month.
Earnings, Forecasting, Pharmaceuticals, Finance
Earnings
Earnings, Finance
Medexus Pharmaceuticals News & Media
Medexus Pharmaceuticals Inc. (MDP:CA) Q4 2026 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (MDP:CA) Q4 2026 Earnings Call June 26, 2026 8:00 AM EDTCompany ParticipantsKenneth d'Entremont - CEO & DirectorBrendon...Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
- Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission - Exclusive licensing and supply agreements have been granted to Medexus for the Canadian commercialization rights for Zemcelpro® (if...Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
- Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission - Exclusive licensing and supply agreements have been granted to Medexus for the Canadian commercialization rights for Zemcelpro® (if...Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsVictoria RutherfordKenneth d'Entremont - CEO...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Medexus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Medexus Pharmaceuticals is a leading innovative and rare disease, pharmaceutical company with a strong North American commercial platform. Medexus Pharmaceuticals is headquartered in Ontario, Canada.... Read More
